Communities Helping the Hearing of Infants by Reaching Parents: The CHHIRP Navigator Trial

社区通过接触父母来帮助婴儿听力:CHHIRP Navigator 试验

基本信息

  • 批准号:
    10378081
  • 负责人:
  • 金额:
    $ 65.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-01 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY As the most common neonatal sensory disorder in the United States, infant hearing loss has an incidence of 1.7 per 1000 births. The consequences of delayed diagnosis and failure to obtain timely intervention include significant communication impairment and negative socioeconomic effects. The overall lifetime medical, educational, and occupational costs due to deafness is estimated to be over $2.1 billion. Early detection of hearing may prevent language development and learning disorders. National standards dictate that all infants should be screened by 1 month of age, diagnosed by 3 months of age, and initiate treatment by 6 months of age (1-3-6 rule) and no more than 10% of infants should be non-adherent to diagnosis within 3 months after birth. In 2015, 59.4% of U.S. infants failed to obtain a diagnosis within 3 months after abnormal screening. There is a need for the development and implementation of interventions that promote adherence to timely diagnosis and treatment standards. Early infant hearing detection and intervention (EHDI) programs are coordinated on a state level, and the diagnostic process is complex and difficult for parents to navigate. Families of children with hearing loss report that they lack confidence and support in obtaining care for their child. Patient navigator (PN) programs have improved adherence to recommended diagnostic testing in cancer care after the detection of a screening abnormality, resulting in substantial healthcare system cost savings. PNs are trained individuals who mitigate barriers to promote healthcare adherence by educating patients and improving self-efficacy. We have recently demonstrated the PN efficacy to decrease non-adherence with infant hearing diagnostic care; however, PN has yet to be tested in diverse communities or implemented into EHDI programs, and there is a gap in this field regarding effectiveness and implementation research on interventions to reduce non-adherence. The proposed research is a community-engaged, type 1 hybrid effectiveness- implementation trial of a PN intervention aimed at decreasing infant hearing diagnosis non-adherence after failed newborn hearing screening, delivered in state-funded EHDI clinics. Guided by our community advisory board and partners, we aim to 1) to test the effectiveness of PN to decrease non-adherence to receipt of infant hearing diagnosis within 3 months after birth using a stepped-wedge trial design, 2) investigate implementation outcomes and factors influencing implementation, and 3) determine the cost-effectiveness of PN from the perspective of third party payers. This study is significant because it aims to reduce non-adherence to timely infant diagnostic hearing testing to prevent life-long negative consequences. This research is innovative in testing an intervention not previously assessed in hearing healthcare within a state-funded EHDI program, and in integrating implementation research and cost-effectiveness methods with our effectiveness aim. Our results will impact the field by partnering with communities to inform the scale-up of this and other innovative patient supportive interventions to create efficient and effective EHDI programs and maximize public health impact.
项目总结 作为美国最常见的新生儿感觉障碍,婴儿听力损失的发病率为 每1000名新生儿中有1.7名。延误诊断和得不到及时干预的后果包括 严重的沟通障碍和负面的社会经济影响。整个一生的医疗, 由于耳聋造成的教育和职业成本估计超过21亿美元。早期发现 听力可能会阻止语言发展和学习障碍。国家标准规定,所有婴儿 应在1个月前进行筛查,在3个月前确诊,并在6个月前开始治疗 年龄(1-3-6规则)和不超过10%的婴儿应在诊断后3个月内未坚持诊断 出生。2015年,59.4%的美国婴儿在异常筛查后3个月内未能获得诊断。 有必要制定和实施干预措施,以促进遵守及时 诊断和治疗标准。早期婴儿听力检测和干预(EHDI)计划 在州一级进行协调,诊断过程复杂,父母很难驾驭。 听力损失儿童的家庭报告说,他们在获得照顾他们的孩子方面缺乏信心和支持 孩子。患者导航仪(PN)计划提高了对癌症推荐诊断测试的依从性 在检测到筛查异常后进行护理,从而大幅节省了医疗系统成本。 PNS是训练有素的个人,他们通过教育患者和 提高自我效能感。我们最近证明了PN对减少婴儿的不依从性的有效性。 听力诊断护理;然而,PN尚未在不同的社区进行测试或实施到EHDI中 方案,这一领域在干预措施的有效性和实施研究方面存在差距 以减少不遵守。拟议的研究是一项社区参与的、类型1的混合有效性- 降低婴幼儿听力诊断不依从性的PN干预的实施试验 未通过新生儿听力筛查,在国家资助的EHDI诊所提供。在我们社区咨询的指导下 董事会和合作伙伴,我们的目标是1)测试PN对减少不遵守婴儿接收的有效性 使用阶梯式楔形试验设计在出生后3个月内进行听力诊断,2)调查实施情况 结果和影响实施的因素,以及3)从以下方面决定PN的成本效益 第三方付款人的视角。这项研究具有重要意义,因为它旨在减少不遵守及时 婴儿诊断性听力测试,防止终生负面后果。本研究在以下方面具有创新性 在国家资助的EHDI项目中测试以前没有在听力保健方面进行评估的干预措施,以及 将实施研究和成本效益方法与我们的实效目标结合起来。我们的结果 将通过与社区合作,告知该患者和其他创新患者的规模扩大,从而对该领域产生影响 支持性干预措施,以创建高效和有效的EHDI方案,并最大限度地发挥公共卫生影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Matthew Lee Bush其他文献

Matthew Lee Bush的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Matthew Lee Bush', 18)}}的其他基金

Appalachian STAR Trial - Revision - Supplemental
阿巴拉契亚 STAR 试验 - 修订 - 补充
  • 批准号:
    10914559
  • 财政年份:
    2023
  • 资助金额:
    $ 65.15万
  • 项目类别:
Appalachian STAR Trial
阿巴拉契亚之星试验
  • 批准号:
    10831880
  • 财政年份:
    2022
  • 资助金额:
    $ 65.15万
  • 项目类别:
Appalachian STAR Trial
阿巴拉契亚之星试验
  • 批准号:
    10619108
  • 财政年份:
    2022
  • 资助金额:
    $ 65.15万
  • 项目类别:
Hearing Healthcare Assessment in Rural Communities (HHARC)
农村社区听力保健评估 (HHARC)
  • 批准号:
    10844668
  • 财政年份:
    2021
  • 资助金额:
    $ 65.15万
  • 项目类别:
Hearing Healthcare Assessment in Rural Communities (HHARC)
农村社区听力保健评估 (HHARC)
  • 批准号:
    10273379
  • 财政年份:
    2021
  • 资助金额:
    $ 65.15万
  • 项目类别:
Appalachian STAR Trial
阿巴拉契亚之星试验
  • 批准号:
    10412885
  • 财政年份:
    2021
  • 资助金额:
    $ 65.15万
  • 项目类别:
Hearing Healthcare Assessment in Rural Communities (HHARC)
农村社区听力保健评估 (HHARC)
  • 批准号:
    10461977
  • 财政年份:
    2021
  • 资助金额:
    $ 65.15万
  • 项目类别:
Communities Helping the Hearing of Infants by Reaching Parents: The CHHIRP Navigator Trial
社区通过接触父母来帮助婴儿听力:CHHIRP Navigator 试验
  • 批准号:
    10600021
  • 财政年份:
    2019
  • 资助金额:
    $ 65.15万
  • 项目类别:
Communities Helping the Hearing of Infants by Reaching Parents: The CHHIRP Navigator Trial
社区通过接触父母来帮助婴儿听力:CHHIRP Navigator 试验
  • 批准号:
    9904600
  • 财政年份:
    2019
  • 资助金额:
    $ 65.15万
  • 项目类别:
Promoting Early Diagnosis of Congenital Hearing Loss through Patient Navigation
通过患者导航促进先天性听力损失的早期诊断
  • 批准号:
    8889813
  • 财政年份:
    2015
  • 资助金额:
    $ 65.15万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 65.15万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 65.15万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 65.15万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 65.15万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 65.15万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 65.15万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 65.15万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 65.15万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 65.15万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 65.15万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了